Aveanna Healthcare Announces 2025 Financial Surge

By Chris Stiles • Thursday, March 19 12:54 • Permanent Link

Aveanna Healthcare Holdings Inc. has announced its fourth quarter and full year 2025 financial results, highlighting substantial growth in various key metrics compared to the prior year period.

For the fourth quarter of 2025, the company reported a revenue of $662.5 million, representing a significant increase of 27.4% over the prior year period. Net income for the same period surged to $178.8 million from $29.2 million in the prior year period. Adjusted EBITDA for Q4 2025 was also impressive, reaching $85.0 million, a substantial 54.0% increase over the prior year period.

Looking at the full year 2025, Aveanna Healthcare Holdings Inc. achieved a revenue of $2,433.2 million, marking a noteworthy 20.2% increase over the previous year. The company's gross margin for the fiscal year ended January 3, 2026, was $810.5 million, representing 33.3% of revenue, compared to $635.5 million or 31.4% of revenue for the fiscal year ended December 28, 2024, showing an increase of $174.9 million or 27.5%.

The company also demonstrated a remarkable turnaround in net income, reporting $225.0 million for the fiscal year ended January 3, 2026, compared to a net loss of $10.9 million for the fiscal year ended December 28, 2024. Adjusted EBITDA for the full year 2025 reached $320.9 million, or 13.2% of revenue, compared to $183.6 million, or 9.1% of revenue for the fiscal year ended December 28, 2024, marking an impressive increase of $137.3 million or 74.8%.

Furthermore, the company maintained its full year 2026 revenue guidance of between $2.54 and $2.56 billion, along with adjusted EBITDA guidance of between $318 and $322 million.

Aveanna Healthcare Holdings Inc. also announced its agreement to acquire Family First Homecare subsequent to the fourth quarter, which is expected to further strengthen its position in the market.

The company's CEO, Jeff Shaner, expressed satisfaction with the results, citing the strength and momentum of all three operating divisions and the completion of the third year of their strategic transformation.

The market has reacted to these announcements by moving the company's shares -5.53% to a price of $9.22. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.